Close Menu
BOSTON — A prospective study by researchers at Zygogen have found what they believe to be the first anti-angiogenic compound initially identified in live zebrafish whose activity they were able to translate to human cell-based assays.
 
Eric Sandberg, a Zygogen scientist, told CBA News this week that up until his firm’s research, all studies looking at the effect of anti-angiogenic compounds in zebrafish were done retrospectively.
 

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

You may already have institutional access!

Check if I qualify.

Already a GenomeWeb or 360Dx Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

Researchers representing scientists and students of Chinese descent voice their concerns about recent US policies and rhetoric.

Wired reports that researchers have shown they could reprogram a DNA-based computer.

Researchers say increased diversity in genomic studies will benefit all, PBS NewsHour reports.

In Science this week: whole-genome sequencing of single sperm cells, and more.